The Federal Reserve’s bank stress test is “capricious” and “arbitrary.” . . . “It’s inconsistent. It’s not transparent. It’s too volatile.” These descriptors came late last week from JPMorgan Chase CEO Jamie Dimon during his bank’s quarterly earnings call. It was a response to results of the latest, annual stress test – the Fed’s response to the 2008 financial crisis to help ensure that large, systemically important banks have sufficient capital buffers to withstand future crises.
COLLEGE PARK, Md. – June 30, 2022 – The Center for Financial Policy at the University of Maryland’s Robert H. Smith School of Business, and Deloitte, will present a Liquidity and Capital Risk Webinar for financial professionals, from 9-10 a.m. Wednesday, July 20, 2022.
The longstanding ‘safe and effective’ regulatory approach to assure Americans their drug products meet a high standard of quality remains effective. However, the pharmaceutical industry needs an additional apparatus – a quality rating system – to address recent supply shortages that are attributable to deficiencies in manufacturing practices, says Maryland Smith’s Clifford Rossi, a risk management expert. Think CMNS nursing home ratings and CARFAX® car history reports, he adds.
The Securities and Exchange Commission’s recently proposed updated rules for public companies to report the climate-related impact of their businesses to the federal government and their shareholders. While the commission collects public comments on the proposal up to June 17, the University of Maryland has crafted a Climate Finance and Risk Management Bootcamp (June 23 and 30) geared to mid-career and senior professionals across industries, who increasingly weigh climate-change factors into business decisions and financial disclosures.
As climate change increasingly affects business decision-making, risk managers, financial analysts and other leaders must anticipate how weather events may impact their growth outlook, estimate how port taxes may increase because of rising sea levels, develop contingencies for supply chain disruptions and respond to the unexpected.
Maryland Smith finance professor Clifford Rossi has been selected by the Food and Drug Administration to serve on its Pharmaceutical Science and Clinical Pharmacology Advisory Committee.
Beyond quantifying and getting their boards to understand traditional financial risks such as credit and market risk, corporate risk officers are grappling with a host of nontraditional risks associated with and ranging from cyber to ESG (environmental, social and governance) and DEI (diversity, equity and inclusion).
As global leaders and business leaders convene in Glasgow for the 26th UN Climate Change Conference of the Parties (COP26), Maryland Smith’s Clifford Rossi will be watching the headlines.
A combination of factors including the current corporate tax rate makes pharmaceutical production in the United States more attractive now than investing in either China or India. And adopting advanced technologies such as Continuous Manufacturing (CM) further positions the United States to recapture a prominent position in pharmaceutical manufacturing.
New ‘Federal Risk Academy’ Certificate Program to Launch from Maryland Smith’s Center for Financial Policy
The Center for Financial Policy (CFP) at the University of Maryland’s Robert H. Smith School of Business and Deloitte have jointly developed a new risk management training program they will deliver to government financial professionals beginning on Jan. 11, 2022. The certificate program, called the Maryland Smith Federal Risk Academy, will provide thought leadership, training, and special events to federal employees engaged in credit, banking, loans, grants, insurance and other market activities.